This report provides an analysis of the Indian pharmaceutical company Cipla Ltd. Key highlights include:
- For the annual period ending March 2012, Cipla reported a 17.03% increase in net profit and 22.24% increase in EBITDA compared to the previous year.
- For the quarter ending September 2012, Cipla reported net profit growth of 500.01% and EBITDA growth of 741.09% over the same quarter of the previous year.
- Cipla has a market capitalization of Rs. 31378.15 crores and the stock is currently trading at Rs. 390.80 per share.